HK175495A - Crystalline salt of 4-(di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz [cd] indole - Google Patents

Crystalline salt of 4-(di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz [cd] indole

Info

Publication number
HK175495A
HK175495A HK175495A HK175495A HK175495A HK 175495 A HK175495 A HK 175495A HK 175495 A HK175495 A HK 175495A HK 175495 A HK175495 A HK 175495A HK 175495 A HK175495 A HK 175495A
Authority
HK
Hong Kong
Prior art keywords
tetrahydrobenz
aminocarbonyl
propyl
amino
indole
Prior art date
Application number
HK175495A
Other languages
English (en)
Inventor
Thomas Joseph Kress
David Lee Varie
Original Assignee
Eli Lilley And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilley And Company filed Critical Eli Lilley And Company
Publication of HK175495A publication Critical patent/HK175495A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK175495A 1990-02-26 1995-11-16 Crystalline salt of 4-(di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz [cd] indole HK175495A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48518590A 1990-02-26 1990-02-26

Publications (1)

Publication Number Publication Date
HK175495A true HK175495A (en) 1995-11-24

Family

ID=23927224

Family Applications (1)

Application Number Title Priority Date Filing Date
HK175495A HK175495A (en) 1990-02-26 1995-11-16 Crystalline salt of 4-(di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz [cd] indole

Country Status (28)

Country Link
US (1) US5397799A (sh)
EP (1) EP0444852B1 (sh)
JP (1) JP3157007B2 (sh)
KR (1) KR100208114B1 (sh)
CN (1) CN1027503C (sh)
AT (1) ATE126506T1 (sh)
AU (1) AU629453B2 (sh)
BR (1) BR9100767A (sh)
CA (1) CA2037099C (sh)
CY (1) CY1887A (sh)
DE (1) DE69112099T2 (sh)
DK (1) DK0444852T3 (sh)
ES (1) ES2077796T3 (sh)
FI (1) FI95464C (sh)
GR (1) GR3017940T3 (sh)
HK (1) HK175495A (sh)
HU (1) HU217118B (sh)
IE (1) IE67801B1 (sh)
IL (1) IL97306A (sh)
LV (1) LV10251B (sh)
NO (1) NO174149C (sh)
NZ (1) NZ237181A (sh)
PT (1) PT96852B (sh)
RU (2) RU2034837C1 (sh)
SG (1) SG69975A1 (sh)
TW (1) TW219933B (sh)
YU (1) YU47594B (sh)
ZA (1) ZA911258B (sh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli Xahydrobenz [DC] Induced indoles in position 6, their preparation process and pharmaceutical preparations containing them
IL97309A (en) * 1990-02-26 1996-11-14 Lilly Co Eli Intermediates for hexahydrobenz] [DC indoles and a process for making their pure enantiomers
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US5643934A (en) * 1991-03-28 1997-07-01 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz [CD]indoles
TW248556B (sh) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
US7588924B2 (en) 2006-03-07 2009-09-15 Procter & Gamble Company Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase
EP3026044B8 (en) * 2006-06-26 2018-12-19 Akebia Therapeutics, Inc. Prolyl hydroxylase inhibitors and methods of use
CN102595896B (zh) 2009-11-06 2016-02-17 爱尔皮奥治疗有限公司 提高低氧诱导因子-1α的稳定性的方法
NO2686520T3 (sh) 2011-06-06 2018-03-17
WO2012170439A1 (en) 2011-06-06 2012-12-13 The Ohio State University Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
CN114404414A (zh) 2013-06-13 2022-04-29 阿克比治疗有限公司 用于治疗贫血症的组合物和方法
AR099354A1 (es) 2013-11-15 2016-07-20 Akebia Therapeutics Inc Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos
WO2016118858A1 (en) 2015-01-23 2016-07-28 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
BR112017021097B1 (pt) 2015-04-01 2024-01-02 Akebia Therapeutics, Inc Formulação de dosagem oral e seu uso
TWI822776B (zh) 2018-05-09 2023-11-21 美商阿克比治療有限公司 用於製備2-[[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基]乙酸之方法
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles

Also Published As

Publication number Publication date
GR3017940T3 (en) 1996-02-29
LV10251B (en) 1995-04-20
CA2037099C (en) 2001-09-11
HU217118B (hu) 1999-11-29
CN1054589A (zh) 1991-09-18
EP0444852A2 (en) 1991-09-04
LV10251A (lv) 1994-10-20
YU47594B (sh) 1995-10-24
IL97306A0 (en) 1992-05-25
US5397799A (en) 1995-03-14
FI910895A (fi) 1991-08-27
ES2077796T3 (es) 1995-12-01
JPH04217662A (ja) 1992-08-07
PT96852A (pt) 1991-10-31
BR9100767A (pt) 1991-10-29
DE69112099D1 (de) 1995-09-21
SG69975A1 (en) 2000-01-25
HUT56542A (en) 1991-09-30
CN1027503C (zh) 1995-01-25
JP3157007B2 (ja) 2001-04-16
NO910735L (no) 1991-08-27
YU32791A (sh) 1994-01-20
FI95464C (fi) 1996-02-12
DE69112099T2 (de) 1996-02-08
RU2083561C1 (ru) 1997-07-10
KR910021375A (ko) 1991-12-20
ZA911258B (en) 1992-10-28
NO910735D0 (no) 1991-02-25
IL97306A (en) 1996-10-16
TW219933B (sh) 1994-02-01
NZ237181A (en) 1992-06-25
AU7197191A (en) 1991-08-29
PT96852B (pt) 1998-07-31
AU629453B2 (en) 1992-10-01
NO174149B (no) 1993-12-13
FI910895A0 (fi) 1991-02-25
IE910625A1 (en) 1991-08-28
ATE126506T1 (de) 1995-09-15
RU2034837C1 (ru) 1995-05-10
FI95464B (fi) 1995-10-31
NO174149C (no) 1994-03-23
CY1887A (en) 1996-04-05
DK0444852T3 (da) 1995-12-11
EP0444852A3 (en) 1992-02-19
EP0444852B1 (en) 1995-08-16
CA2037099A1 (en) 1991-08-27
KR100208114B1 (ko) 1999-07-15
IE67801B1 (en) 1996-05-01

Similar Documents

Publication Publication Date Title
GR3017940T3 (en) Crystalline salt of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz[cd]indole.
AU6666990A (en) Indole derivatives
IE782325L (en) TETRAHYDROBENZ £cd| INDOLES
YU16989A (en) Amfiregulin - new bifunctional glicoprotein for growth modulation
AU3430689A (en) Prevention of lens-related tissue growth in the eye
PL295148A1 (en) Method of obtaining novel derivatives of (3 r,4 s)-azetydynone-2
AU2867689A (en) Felt-like implant
AP9400706A0 (en) Indole derivatives, method of preparation and use
RU92004575A (ru) Кристаллическая соль 4-(ди-н-пропил) амино-6-аминокарбонил-1,3,4,5-тетрагидробенз (cd) индола и ее 4p и 4s-изомеры
ZA905524B (en) Indole derivatives
HU9302749D0 (en) 6-heterocyclic-4-amino-1`,3,4,5-tetrahydrobenz/cd/indoles
AU7418887A (en) Indole derivatives
AU8240791A (en) 6-substituted-hexahydrobenz(cd)indoles
AU7476787A (en) Indole derivatives
AU590603B2 (en) A method of preparing indoles or indole derivatives, coupled via position 4, 5, 6, or 7, the indoles or indole derivatives concerned, as well as the use thereof
AU6969687A (en) 2', 3', 4', 10'-tetrahydro-10'-substituted-10'-hydroxy-spiro ((cycloalkane or heterocyclic)-pyrimido(1,2a)indoles
AU2803689A (en) Certain 3-substituted 2- alkyl indole derivatives
AR243206A1 (es) Procedimiento para la obtencion de polimerizados de propileno-etileno
PL286424A1 (en) Method of obtaining novel indole derivatives
PL274219A1 (en) Method of obtaining novel derivatives of 4-oxo-1,2,3,4-tetrahydrocinnoline
IE862252L (en) "a method of preparing indoles or indole derivatives,¹coupled via position 4,5,6, or 7, the indoles or indole¹derivatives concerned, as well as the use thereof"
GB8814162D0 (en) Indole derivatives
HU207530B (en) Process and medium for cultivating plant- or animal-celles and tissues

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070226